Anti-vascular endothelial growth factor therapy in the treatment of age related macular degeneration, post-trombotic retinopathy, diabetic macular edema and myopic chorioretinal neovascularization
Intravitreal administration of angiogenesis inhibitors in age-related macular degeneration, post-thrombotic retinopathy, diabetic macular edema, and myopic chorioretinal neovascularization.
